Cargando…

Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells

MCL-1 (BCL-2 family anti-apoptotic protein) is responsible for melanoma's resistance to therapy. Cancer initiating cells also contribute to resistance and relapse from treatments. Here we examined the effects of the MCL-1 inhibitor SC-2001 in killing non melanoma-initiating-cells (bulk of melan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mukherjee, Nabanita, Lu, Yan, Almeida, Adam, Lambert, Karoline, Shiau, Chung-Wai, Su, Jung-Chen, Luo, Yuchun, Fujita, Mayumi, Robinson, William A., Robinson, Steven E., Norris, David A., Shellman, Yiqun G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564524/ https://www.ncbi.nlm.nih.gov/pubmed/27086916 http://dx.doi.org/10.18632/oncotarget.8695

Ejemplares similares

Alternative treatments for melanoma: targeting BCL-2 family members to de-bulk and kill cancer stem cells
por: Mukherjee, Nabanita, et al.
Publicado: (2015)

Combining a BCL2 Inhibitor with the Retinoid Derivative Fenretinide Targets Melanoma Cells Including Melanoma Initiating Cells
por: Mukherjee, Nabanita, et al.
Publicado: (2014)

MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells
por: Mukherjee, Nabanita, et al.
Publicado: (2020)

Enrichment of Melanoma Stem-Like Cells via Sphere Assays
por: Mukherjee, Nabanita, et al.
Publicado: (2021)

Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma
por: Mukherjee, Nabanita, et al.
Publicado: (2020)

A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine
por: Dart, Chiara R., et al.
Publicado: (2021)

Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments
por: Mukherjee, Nabanita, et al.
Publicado: (2016)

ABT-737 synergizes with Bortezomib to kill melanoma cells
por: Reuland, Steven N., et al.
Publicado: (2011)

BH3 mimetics induce apoptosis independent of DRP-1 in melanoma
por: Mukherjee, Nabanita, et al.
Publicado: (2018)

The Combination of BH3-Mimetic ABT-737 with the Alkylating Agent Temozolomide Induces Strong Synergistic Killing of Melanoma Cells Independent of p53
por: Reuland, Steven N., et al.
Publicado: (2011)

NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma
por: Zhai, Zili, et al.
Publicado: (2017)

CtBP1 is expressed in melanoma and represses the transcription of p16INK4a and Brca1
por: Deng, Hui, et al.
Publicado: (2013)

Transcriptome Profiling of Whole Blood Cells Identifies PLEK2 and C1QB in Human Melanoma
por: Luo, Yuchun, et al.
Publicado: (2011)

Dual role of apoptosis-associated speck-like protein containing a CARD (ASC) in tumorigenesis of human melanoma
por: Liu, Weimin, et al.
Publicado: (2012)

Side Population Cells from Human Melanoma Tumors Reveal Diverse Mechanisms for Chemoresistance
por: Luo, Yuchun, et al.
Publicado: (2012)

Ellagic acid inhibits melanoma growth in vitro
por: Jensen, J. Daniel, et al.
Publicado: (2011)

MicroRNA-26a is Strongly Down-regulated in Melanoma and Induces Cell Death through Repression of Silencer of Death Domains (SODD)
por: Reuland, Steven N., et al.
Publicado: (2012)

Targeting Melanoma with Cancer-Killing Viruses
por: Zhang, Tiantian, et al.
Publicado: (2017)

Overexpression of Mcl-1 confers resistance to BRAF(V600E) inhibitors alone and in combination with MEK1/2 inhibitors in melanoma
por: Fofaria, Neel M., et al.
Publicado: (2015)

Ethanol Metabolism and Melanoma
por: Zhai, Zili, et al.
Publicado: (2023)

Killing effect of methionine enkephalin on melanoma in vivo and in vitro
por: Wang, Dong-Mei, et al.
Publicado: (2017)

Apoptosis Induced by Ginkgo biloba (EGb761) in Melanoma Cells Is Mcl-1-Dependent
por: Wang, Yufang, et al.
Publicado: (2015)

Combined Mcl-1 and YAP1/TAZ inhibition for treatment of metastatic uveal melanoma
por: Glinkina, Kseniya A., et al.
Publicado: (2023)

Demethylzeylasteral inhibits cell proliferation and induces apoptosis through suppressing MCL1 in melanoma cells
por: Zhao, Yuzu, et al.
Publicado: (2017)

BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
por: Lee, Erinna F., et al.
Publicado: (2019)

The killing effects of 4-S-cysteinylcatechol and analogues on human melanoma cells.
por: Yamada, I., et al.
Publicado: (1988)

Importance of Mcl-1 for Alveolar Macrophage Apoptosis–associated Bacterial Killing
por: Stout-Delgado, Heather W.
Publicado: (2019)

Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy
por: Amato, Carol M., et al.
Publicado: (2020)

Skin check partner assistance for melanoma skin self-examination by at-risk patients: it takes two to identify melanomas
por: Robinson, June K
Publicado: (2020)

Selective Induction of Cell Death in Melanoma Cell Lines through Targeting of Mcl-1 and A1
por: Senft, Daniela, et al.
Publicado: (2012)

Proteasomal Degradation of Mcl-1 by Maritoclax Induces Apoptosis and Enhances the Efficacy of ABT-737 in Melanoma Cells
por: Pandey, Manoj K., et al.
Publicado: (2013)

Specifically targeting ERK1 or ERK2 kills Melanoma cells
por: Qin, Jianzhong, et al.
Publicado: (2012)

Preferential killing of melanoma cells by a p16-related peptide
por: Soo, Julia K., et al.
Publicado: (2023)

Para-Phenylenediamine Induces Apoptotic Death of Melanoma Cells and Reduces Melanoma Tumour Growth in Mice
por: Bhowmick, Debajit, et al.
Publicado: (2016)

Oncolytic viruses in melanoma
por: Robinson, Camille, et al.
Publicado: (2022)

Physical activity of early stage melanoma survivors()()
por: Robinson, J.K.
Publicado: (2018)

A simple technique for quantifying apoptosis in 96-well plates
por: Ribble, Deborah, et al.
Publicado: (2005)

MCL-1, BCL-X(L) and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in Microenvironment
por: Hartman, Mariusz L., et al.
Publicado: (2015)

Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors
por: Sale, Matthew J., et al.
Publicado: (2019)

LiCl induces apoptosis via CHOP/NOXA/Mcl-1 axis in human choroidal melanoma cells
por: Zhang, Qiuqiu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jv3qvu052g61nb96d9opjnq4o1